[–] 5 points 3 months ago

ThinkPads have to be the gold standard for Linux laptops, so id be surprised if battery management wasn't something they could control (i.e. stay 80% charged)

Though, why keep the spicy pillow at all? Take the battery out and just make it a normal computer attached to your nas. In a power outage your Nas won't have power anyway, and if you have a ups it could also run the laptop... A spicy pillow always powered on is just a consumable you have to manage

  • source
  • [–] 3 points 3 months ago (4 children)

    i've been wary of all industrial fats - sadly any liquid at room temperature fat (olive oil and avacado oil) is just too temping to adulterate with the cheaper industrial fats, so the supply chain does it at scale - so I don't trust any liquid at room temperature fat anymore.

  • source
  • parent
  • context
  • [–] [S] 2 points 3 months ago (3 children)

    There is a list! the spoilers in the post expand to the book list with links (well, mostly, some of the books didn't get scanned, but its mostly complete)

    Yes - A fall of moondust! Rama was really a great story both about meta-structures where we are not the main character, and how human colonies morph over time - it wet my appetite for Ringworld - which i cannot recommend enough.

    I'm partial to Bradbury's "There will come soft rains", mostly because a civilization has echo's through time and even if ours falls we are not totally gone.

    I have not had the pleasure of reading Think Like a Dinosaur yet, but i will soon!

  • source
  • parent
  • context
  • [–] [S] 2 points 3 months ago (5 children)

    lemmy downsampled the photo anyway, so the details are a bit hard to see. I love the Clarke books! There was one about moon dust, i forgot the name, but it was very impactful when i read it as a kid. . I don't know Gibson i'll look them up. I think Bradbury is my favorite of all, small short stories but plenty of "quiet" ideas that sit with you. I think Asmiov really shines in short stories, i found the foundation series went on a bit too long and kinda repeated the same gimmick over and over.

    I'll take a look at He Who Fight with Monsters as well.

    The original hitchhikers bbc radio radio dramas sit well with me more than the books, i will check out the DCC audiobooks for that reason alone, thanks for the pointer.

  • source
  • parent
  • context
  •  

    Exogenous ketones have exploded in popularity, with claims ranging from better brain function to improved performance and weight loss. But what does the science actually say?

    In this in-depth conversation, Dr. Bret Scher sits down with leading ketone researcher Dr. Dominic D'Agostino (@ketonutrition-dom4845) to break down the reality behind exogenous ketones—what they are, how they work, and where they may (or may not) fit into your health strategy.

    They explore the key differences between:

    • Endogenous ketones (produced by your body through diet or fasting)
    • Exogenous ketones (supplements you consume)

    And why that distinction matters for both metabolic and brain health.

    This conversation covers:

    • The different types of exogenous ketones (salts, esters, those derived from MCTs)
    • Potential benefits for brain energy, seizures, and metabolic health
    • Safety considerations and why formulation matters
    • Why exogenous ketones are best viewed as a tool, not a replacement for a ketogenic diet
    • The concept of a “sweet spot” for ketone levels in different conditions

    One of the biggest takeaways: context is everything. Exogenous ketones may offer the most benefit when used to support a well-formulated metabolic approach, rather than as a standalone shortcut.

    summerizerCore thesis

    • Exogenous ketones are strongest when a metabolic deficit or brain energy bottleneck exists.
    • They augment ketogenic diet efficacy; the diet usually does most of the work for most uses.
    • A ketogenic diet changes substrate availability and metabolic physiology, while a ketone drink mainly raises circulating ketones.
    • High glucose, high insulin, and high ketones together create an uncommon fuel state that may create energy toxicity or reductive stress.

    Ketosis routes and formulations

    • Ketosis can come from fasting, ketogenic diets, ketogenic fats such as MCT oil, ketone salts, ketone acids, and ketone esters.
    • MCT oil goes to the liver quickly and can raise endogenous ketones, but it is a saturated fat and may raise LDL in some people.
    • The liver makes ketones but cannot use them well because it lacks succinyl-CoA transferase, so ketones move into circulation for the brain, heart, kidneys, and muscle.
    • Plain beta-hydroxybutyric acid is acidic; larger unbuffered doses can transiently push acid-base status toward metabolic acidosis in healthy users.
    • Ketone salts buffer beta-hydroxybutyrate or acetoacetate with minerals and usually have a self-limiting mineral load.
    • Ketone esters bind ketones to another molecule through an ester bond; 1,3-butanediol based esters require liver conversion and have tolerability and long-term data limits.
    • The 1,3-butanediol load at common daily amounts makes the liver work like it does with ethanol on a per-gram basis in D'Agostino's account.

    Clinical use and dosing logic

    • Exogenous ketones are strongest as an add-on to ketogenic diets for brain-centered conditions, not as a stand-alone method.
    • Epilepsy can require maintained ketones around 3 to 5 mmol/L for some pediatric cases, while other people feel worse above 2 to 3 mmol/L.
    • Cancer metabolism work uses lower ketone ranges around 1 to 2 mmol/L, because higher ketones are not always the target.
    • Subjective function and objective measures such as glucose, ketones, GKI, PHQ-9, or GAD-7 are paired with clinical goals.
    • Smaller doses, food, MCT oil, fat, fiber, and protein can slow absorption and make ketone administration safer.
    • Large fasting doses can be risky when a person is already ketotic.

    Safety concerns and individual response

    • Large ketone ester doses can raise insulin, lower endogenous beta-oxidation, and later leave ketones and glucose low.
    • Ketone salts did not raise insulin in D'Agostino's experience, because mineral load limits the dose.
    • MCT oil is a conservative first option for raising ketones, but empty-stomach use often causes gastrointestinal problems.
    • DL beta-hydroxybutyrate salts are the next conservative option in D'Agostino's practical hierarchy.
    • D-beta-hydroxybutyrate may be more direct for energy, while L-beta-hydroxybutyrate clears more slowly and may have stronger signaling effects.
    • Combining MCT, DL beta-hydroxybutyrate salt, and limited acid can sustain ketones better than a single ketone molecule.

    Evidence and open areas

    • Animal hyperbaric oxygen experiments used acute ketone administration before 5 ATA oxygen exposure and found seizure delays in the 200% to 600% range.
    • Human RCT data exist but are small; larger human studies are still needed for clinical uses.
    • A recent low-dose beta-hydroxybutyrate RCT used 2 grams and found psychomotor vigilance and possible grip-strength signals.
    • D and L enantiomer pharmacokinetics, brain uptake, and brain effects remain an active area.
    • Exogenous ketones may have a trajectory similar to creatine, with early sports use followed by broader work in cognition, mood, sleep deprivation, and aging.

    D'Agostino's personal regimen and monitoring

    • D'Agostino now uses a low-carbohydrate Mediterranean-style diet that often sits near mild ketosis.
    • D'Agostino adds DL beta-hydroxybutyrate salts, often with creatine monohydrate, to raise ketones modestly.
    • D'Agostino uses exogenous ketones for sustained energy and appetite reduction more than weightlifting performance.
    • D'Agostino had years of high LDL and ApoB on ketogenic diets, later shifted toward lower-carbohydrate Mediterranean eating, and monitors blood markers closely.
    • D'Agostino's monitoring includes lipid markers, inflammation markers, glucose markers, omega-3 status, heavy metals, metabolomics, and vascular imaging.

    Practical takeaways

    • The choice of ketone product depends on goal, baseline metabolic state, dose, formulation, timing, and measured response.
    • Brain energy conditions are the main area where ketone level targeting may matter most.
    • Weight loss marketing is less central than metabolic and neurological use here.
    • Long-term human data are limited, so clinical teamwork and lab monitoring matter when ketones are used for specific conditions.
    • Ketone salts and MCT-based approaches are the favored conservative starting points; 1,3-butanediol-heavy esters receive the most caution.

    References

     

    GLP-1 receptor agonists like semaglutide are often described as “game changers” for weight loss and cardiovascular health, and in many ways, the data support that claim. Clinical trials suggest meaningful reductions in major cardiovascular events, offering hope for individuals struggling with metabolic disease.

    But there’s an important nuance that deserves more attention: what happens when these medications are stopped?

    In this conversation, Dr. Bret Scher explores emerging real-world data showing that the benefits of GLP-1s, particularly for cardiovascular risk, appear to depend on continued use. For many individuals, stopping the medication leads to a reversal of progress, raising important questions about long-term strategy, sustainability, and what true metabolic healing looks like.

    • Are we managing symptoms, or addressing root causes?\
    • What role should medications play in long-term care?\
    • How can we use powerful tools like GLP-1s to *support*, rather than replace, sustainable metabolic change?

    For some individuals, long-term use may be appropriate and beneficial. But we need to broaden the conversation toward approaches that aim to improve underlying metabolic health, support lasting behavior change, and ultimately reduce reliance on lifelong interventions when possible.

    If you’re exploring GLP-1s or are currently taking one, consider speaking with your healthcare provider about how to pair your treatment with sustainable lifestyle strategies such as nutrition, physical activity, and metabolic support, to help maintain progress over time.

    - How do GLP-1 medications impact mental health? Learn more on our blog: https://www.metabolicmind.org/resources/library/videos/ozempic-wegovy-and-mental-health-are-glp-1-drugs-linked-to-suicidal-thoughts>

    summerizerCardiovascular benefit during use

    • GLP-1 medications such as semaglutide have cardiovascular benefit while they are being taken and affect weight loss and heart care.
    • Large clinical trials show a 15% to 20% relative reduction in major cardiovascular events over five years, or about a 1.5% to 2% absolute reduction.
    • Those numbers make the drugs look like a broad answer to the metabolic health crisis.
    • The key question is what happens after people stop taking them.

    What happens after discontinuation

    • In the real world, many people stop, with roughly one-half to two-thirds off the drugs within a year.
    • A BMJ Medicine study in a VA cohort of more than 300,000 patients examined outcomes after discontinuation.
    • Continuous GLP-1 use was associated with about an 18% lower risk of heart attack, stroke, or death than sulfonylurea use.
    • Use for 18 months or less had no clear cardiac benefit.
    • Benefits started receding within six months of stopping and were essentially gone within 18 months.
    • Cardiovascular protection depended on ongoing use.

    Why the benefit fades

    • The medication manages the problem without removing its deeper drivers.
    • GLP-1s can lower weight and temporarily improve metabolic health.
    • They do not by themselves rebuild eating patterns, physical fitness, metabolic flexibility, or other long-term drivers of cardiometabolic disease.
    • When lifestyle and metabolic drivers stay the same, risk returns when the medication is removed.
    • Because the study population was drawn from the VA, cost pressure on adherence was muted, and discontinuation could be even more common where copays are higher.

    How the medication fits into care

    • Lifelong use may make sense for some high-risk patients, but lifelong dependence for millions is not the goal.
    • GLP-1s are a powerful short-term tool that reduces hunger, quiets food noise, triggers weight loss, and creates room for change.
    • That window should be used to build durable nutrition habits, higher protein intake, lower refined carbohydrate intake, physical activity, and muscle preservation.
    • Relying on the drug alone leads to weight regain, worsening metabolic markers, and loss of cardiovascular benefit when use stops.
    • The aim is durable cardiovascular, metabolic, and mental health rather than a temporary reduction in risk.

    Stewardship and implementation

    • Proper stewardship matters because these medications are becoming more common, not less.
    • Individuals and clinicians are responsible for using them in ways that pair medication benefit with long-term metabolic recovery.
    • The Coalition for Metabolic Health recently formed a GLP-1 task force and has a paper on GLP-1 medications and metabolic health.

    References

     

    Lecture presentation at deep river library on new book acquisition April 17, 2026

    summerizerPurpose and learning stance

    • A 16-chapter, 640-page book on nuclear reactor core materials is the basis of this mostly non-technical talk.
    • The book comes from enough years in the field to connect ideas that were not obvious earlier.
    • Writing the book forced a return to old physics lessons and later understanding of what earlier lecturers had meant.
    • The book is for a younger engineer and for young engineers and scientists of ordinary ability who are willing to learn.
    • Learning begins with accepting that there is still something to learn. Confidence, humility, and engineering culture
    • Dunning-Kruger is a competence-confidence pattern tied here to much older observations by Machiavelli and Schopenhauer.
    • More learning brings a clearer view of the limits of knowledge.
    • The PhD viva left Malcolm feeling tiny, and his supervisor saw that feeling as proof that the process had done its job.
    • Research and management kept dividing people into two groups: receptive people who listened and unreceptive people who stayed willfully ignorant.
    • A little knowledge around reactor materials is dangerous because people can mistake shallow familiarity for understanding.
    • At Chalk River a supposedly surprising pressure-tube result fit the sample location, yet others reached the same answer only two years later.
    • At Queen's a DFT paper had omitted earlier work that cut against both the data interpretation and the theoretical assumptions.
    • Receptive people also stood out: a summer student and an Idaho project officer absorbed in hours what formal settings had not taught in much longer spans.

    Atomic structure and deformation

    • Metal atoms behave like hard spheres whose bonding and packing drive crystal structure.
    • Close packing gives two main structures for common reactor metals: ABA stacking for hexagonal close-packed crystals and ABC stacking for face-centered cubic crystals.
    • FCC and HCP cover many reactor-core materials, but they are only two of the 14 crystallographic arrangements.
    • Crystal structure mattered enough to supply a joke about Bristol buildings looking orthorhombic rather than monolithic.
    • Plastic deformation in crystals proceeds through slip, twinning, and martensitic change, and engineering alloys add grain boundaries to that picture.
    • Grain boundaries are stronger than the grains because the regular atomic arrangement inside grains makes deformation easier there.
    • Dislocations are line defects where bonds have been broken locally, and they let metals deform by sequential bond breaking and reforming instead of one huge shear event.
    • A caterpillar ripple, moving a carpet, and tearing a telephone book a few pages at a time capture how dislocations lower the needed force.

    Radiation damage and microscopy

    • Neutron bombardment creates point defects when enough energy is transferred to knock atoms out of lattice sites.
    • A fast neutron can launch a displacement cascade, and even thermal neutrons can create a few displacements through recoil from emitted gamma radiation.
    • Nickel is especially important because nickel-58 can transmute to nickel-59, and nickel-59 then drives extra damage while producing hydrogen and helium.
    • The displaced atoms and the vacancies they leave behind can migrate, cluster, and change microstructure and material properties.
    • Transmission electron microscopy lets these defects and diffraction effects be seen directly, including vacancy loops and interstitial loops.
    • High-voltage microscopy allows thicker samples and in-situ irradiation, so defect motion can be watched while damage is being created.
    • In Stuttgart a vacancy loop grew during irradiation at 300 C, which showed that vacancies were mobile under those conditions.
    • Radiation can also drive phase change, including an amorphous transformation in a zirconium precipitate first seen at Chalk River by Ross Gilbert.
    • A zoom from that precipitate out to the M13 globular cluster made the point that structure can look surprisingly similar across radically different length scales.

    Practical reactor materials and components

    • Calandria tubes and pressure tubes have distinct microstructures, and pressure tubes matter because they are the pressure boundary inside the core.
    • Cold-worked pressure tubes contain an enormous dislocation density, enough that a cubic centimetre would stretch from Earth to the Moon and a full tube would reach Pluto and back twice if the lines were joined end to end.
    • Heavy-water CANDU reactors run on natural uranium, use heavy water for coolant and moderator service, and rely heavily on zirconium alloys because zirconium absorbs few neutrons.
    • Some internal parts still need nickel alloys, and the garter spring is a critical nickel-alloy spacer that keeps the hot pressure tube away from the colder calandria tube.
    • Contact between those tubes creates a cold spot, blister formation, and possible tube failure, which is why earlier failures in 1983 and 1986 mattered so much. Spacer failures, helium, and irreversibility
    • A spacer removed after about 15 years in service arrived broken into many pieces, and truck transport did not cause that damage.
    • Transit simulation showed that an unirradiated spacer could be deformed but was hard to break, while gentle cyclic bending could break it by fatigue like a paper clip.
    • The irradiated spacer fractured differently, with faceted grain-boundary fracture rather than the fatigue surface of unirradiated material.
    • Malcolm recognized that brittle intergranular behavior as helium embrittlement and had a hard time convincing others that CANDU conditions generate that much helium.
    • The helium level was put at roughly a hundredfold above comparable U.S. reactor conditions for this kind of material.
    • In a heavily damaged sample without helium, grain boundaries stayed comparatively clean even after about 500 displacements per atom.
    • With helium in the material, vacancies were stabilized at grain boundaries and perforated the boundary instead of being absorbed.
    • Annealing does not solve that problem because helium stays in the material.
    • Helium is forever.

    References

     

    Ever wonder why Task Manager shows a CPU value that doesn't "feel" right? Dave explains why Task Manager shows you the values it does and how they are determined.

    summerizerWhat the CPU percentage is

    • Task Manager does not read a single instantaneous "CPU busy" value from Windows.
    • The percentage is a periodic summary of activity that happened between refreshes.
    • The display timer controls when the UI updates, but it does not supply the CPU denominator.
    • CPU usage is an accounting result built from choices about cores, modes, idle time, interrupts, DPCs, and averaging windows.

    How the percentage is computed

    • Task Manager asks the kernel for cumulative per-process execution time, split across user time and kernel time.
    • Each process behaves like an odometer: the code reads the running total, subtracts the last sample, and gets that process's CPU delta for the interval.
    • The code also does a full pass across the process table, sums all current cumulative times, subtracts the previously remembered total, and gets the system-wide total delta.
    • The per-process CPU percentage is that process delta divided by the total delta across all processes during the same sample window.
    • This keeps the result meaningful even when the UI timer fires late or unevenly.
    • The old code uses integer arithmetic and rounding to produce a fast, stable percentage without floating-point work in a hot UI path.

    Why the number can feel wrong on modern hardware

    • The meter answers how long a process was scheduled, not how many cycles or how much work the hardware delivered during that time.
    • Dynamic frequency scaling, turbo behavior, thermal limits, deep sleep modes, and parked cores break the old assumption that a second of scheduled CPU time maps cleanly to a fixed amount of work.
    • A process can show about 50% CPU for half of a sample window even though the actual work done in that half-window can vary widely with clock speed.
    • The percentage is closer to occupancy than productivity.

    Why totals, cores, and idle time confuse people

    • On a multicore system, the process column answers what share of total machine CPU capacity a process consumed during the sample window.
    • One process fully saturating one core on an 8-core machine lands near 12% to 13% of total machine capacity, not 100%.
    • The System Idle Process is the bucket for unclaimed cycles, so busy time plus idle time adds up to the full machine total for the interval.
    • The number is an average over the recent refresh window, so a short burst can be diluted into a small value or rounded to zero.
    • Watching total CPU can hide a single saturated core, especially on machines with many cores or threads.

    Why the code contains clamps, assertions, and edge cases

    • The code clamps computed CPU above 99 back to 99 because early builds sometimes produced totals above 100% from a rare kernel-side accounting anomaly.
    • The bug was trapped with assertions and eventually confirmed and fixed on the kernel side.
    • The code invalidates old process records when cumulative CPU time moves backward, because PID reuse can make one dead process and one new process share the same identifier across samples.
    • The code also marks an idle-process time of exactly zero as bogus and invalidates it.
    • WOW tasks add another accounting wrinkle: child 16-bit task times are capped so they do not exceed the parent NTVDM total.

    What the tool is for

    • CPU usage is a ratio assembled from accounting decisions, not a substance that exists on its own.
    • Task Manager favors a cheap, robust, human-readable approximation over a more forensic display.
    • A 0% reading can still mean less than 1% average activity in the sample window, and a bouncing 0%, 6%, or 12% can match a bursty worker thread behaving normally.
    • Catching microstutters, scheduler hiccups, or DPC storms needs a more specialized view than a one-second UI average.
    • The old Windows NT4 Task Manager still runs on Windows 11, groups CPUs in sets of 16, and shows how much of the original design still survives.
    • The final number is a fast, useful summary of a complicated reality, as long as it is read as an accounting ledger instead of a thermometer.

     

    TLDW: Overall health improves, metabolic problems drastically reduce. Regenerative farming takes over.

    summerizerA different default world

    • Health is normal, children wake rested, and families feed them simple animal-based meals that leave them fueled and steady.
    • Schools serve eggs, ground beef, and sausage in place of sugary breakfast foods, and teachers see calmer energy, better focus, and less irritability.
    • Childhood obesity, fatigue, and fatty liver are rare enough to cause concern and do not fade into the background of daily life.
    • Farms raise animals with care, restore land, and reconnect food production with family health. Root-cause medicine
    • Doctors start with nourishment, metabolism, insulin resistance, and root cause before disease management.
    • A well-fed body changes hormones, hunger, inflammation, and the mind.
    • Preventive sickness is not normal, and middle-age decline is not an unavoidable baseline.
    • The body needs essential amino acids and essential fatty acids, while carbohydrate is common and marketed but not essential.

    Carnivore against the standard narrative

    • Carnivore challenges assumptions, industries, and experts who keep repeating ideas that are not working.
    • Protein and fat are the body’s true needs, and meat supplies highly bioavailable nutrients the body can use.
    • Many people feel better because they remove ultra-processed foods, stabilize blood sugar, improve satiety, and reduce inflammatory triggers.
    • The outrage around carnivore centers on identity, worldview, and discomfort when something expected to fail helps people feel human again.

    Limits, gaps, and practical caution

    • Carnivore is not perfect for every person or every circumstance forever.
    • There are evidence gaps, long-term questions, and people who need guidance.
    • Some people do better with broader low-carb or ketogenic approaches.
    • People may need to monitor electrolytes, digestion, medications, and adaptation symptoms.

    Strength, mission, and the future

    • Repeated improvement in patients makes this bigger than a menu choice and turns it into a movement and a fight for the future.
    • A better society is built through small daily decisions repeated with purpose across meals, families, farms, clinics, and schools.
    • This way of eating brings steadiness, clarity, focus, endurance, discipline, and the energy to resist systems that weaken people.
    • The goal is a world where children are strong, families understand nourishment, real food returns to the center, and metabolic disease becomes rare.

    References

     

    TLDR: People don't need carbohydrates, ketosis isn't dangerous.

    It is pertinent to briefly discuss the enduring misconception that glucose itself represents an “absolutely essential”, “universal fuel” in human physiology, which requires nuanced definition and gradation, but has been perpetuated verbatim and may have been incorporated into the physiology education of currently practicing healthcare professionals [1-7].

    We must first address the distinction between endogenous and exogenous sources of glucose. Clinical trials and epidemiological studies of very low to zero carbohydrate diets support the statement of the US National Academies of Sciences that “the lower limit of dietary carbohydrate compatible with life apparently is zero, provided that adequate amounts of protein and fat are consumed” [8-11]. Even so, despite seemingly safe and increasingly popular, the long-term effects of a truly “zero” carbohydrate diet (without micronutrient supplementation) are difficult to ascertain through controlled experimentation, being only inferred from evolutionary biology, observational studies, and mechanistic data [12-14]. With this caveat, it has now been clearly established in large cohorts of patients, both adult and pediatric, that the oral intake of carbohydrates can be chronically very low (< 5-10% of total daily energy), as long as essential micronutrients are obtained from the underlying food selection and/or supplementation [15-18].

    During fasting or in the absence of dietary carbohydrates, a steady-state euglycemia will be maintained in a low but physiological range via hepatic and renal gluconeogenesis from endogenous sources, such as lactate, fatty acids (glycerol), gluconeogenic amino acids and odd chain fatty acids [19-21]. From an evolutionary perspective, a minimal threshold of gluconeogenesis was preserved even after indefinite periods of fasting, questioning whether glucose itself is essential [22, 23]. It was not until the seminal work of Cahill et al. corroborating the remarkable metabolic flexibility of human physiology that the absolute requirements of glucose under compensatory ketosis could be quantified [24]. Drenick et al. demonstrated that, after a 2-month fast in obese subjects, insulin stimulation failed to precipitate hypoglycemic reactions with plasma glucose as low as 9 mg/dl (0.5 mM) [25]. During prolonged fasting, blood glucose levels below 30 mg/dL (1.70 mM) have been sustained continuously for several months without adverse effects [22, 23]. It is apparent that glucose requirements can be significantly displaced by fat-derived fuels, assuming a gradual period of ketogenic adaptation proportional to the degree of glucose depletion [26, 27]. Most human tissues require at least 1 to 4 weeks of strict KD adherence for the effective upregulation of ketone body metabolism, a process that can be accelerated through water-only fasting [28-30]. Without ketogenic adaptation, glucose is indeed the “primary metabolic fuel”, as evidenced by hypoglycemic reactions after accidental secretagogue or insulin overdose in diabetic patients following carbohydrate-rich diets, even under conditions of diabetic ketoacidosis [31-33].

    Many clinicians fear ketosis due to confusion with diabetic ketoacidosis, defined by the triad of excessive ketogenesis, metabolic acidosis and concomitant hyperglycemia [34]. A low level of ketones (e.g., < 0.5 mM) prior to initiating carbohydrate restriction indicates that the individual is likely not deficient in insulin and therefore not at risk for ketoacidosis [35]. Clinicians may wish to monitor serum bicarbonate during the early stages of ketogenic adaptation. Ketoacidosis does not occur unless ketones coexist with hyperglycemia and decreasing bicarbonate levels, indicating insulin insufficiency (not to be confused with insulin suppression via carbohydrate restriction, which in turn increases insulin sensitivity, as indicated by lower insulin requirements for euglycemia) [36].

    In the context of KMT, evolutionary competition for the limited nutrient supply between the tumor and normal tissues may be potentiated [37]. It is important to clarify that the uninterrupted maintenance of very low glucose levels (< 3 mM) is not realistically achievable for most patients following isocaloric KDs and typically requires prolonged fasting or pharmacological interventions. Fortunately, the anti-tumoral benefits of KMT are hypothesized to arise from pleiotropic regulation of energy sensing and growth signaling pathways (PI3K, AKT, AMPK/mTOR, PGC-1α), inflammation, angiogenesis, and autophagy, not solely as the result of reduced glucose availability with compensatory ketosis, which simply serves as a surrogate marker for successful clinical implementation [38-43].

    Ok, this isn't a whole paper by itself, its an appendix of Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma But its so well written, it deserves to be highlighted.

    Full Original Paper here: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03775-4#Sec31 - Supplementary Material 1 - Appendix 1 - Warning - It's a docx document.

    references 1-43

    1. Nakrani MN, Wineland RH, Anjum F: Physiology, Glucose Metabolism. StatPearls 2022.
    2. Mathew P, Thoppil D: Hypoglycemia. In: StatPearls [Internet]. edn.: StatPearls Publishing; 2022.
    3. Ritter S: Monitoring and maintenance of brain glucose supply: importance of hindbrain catecholamine neurons in this multifaceted task. Appetite Food Intake 2017:177-204.
    4. Mergenthaler P, Lindauer U, Dienel GA, Meisel A: Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 2013, 36(10):587-597.
    5. Luz MR, de Oliveira GA, de Sousa CR, Da Poian AT: Glucose as the sole metabolic fuel: The possible influence of formal teaching on the establishment of a misconception about energy‐yielding metabolism among students from Rio de Janeiro, Brazil. Biochemistry molecular biology education 2008, 36(6):407-416.
    6. Ghosh A, Cheung YY, Mansfield BC, Chou JY: Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 2005, 280(12):11114-11119.
    7. Brosnan JT: Comments on metabolic needs for glucose and the role of gluconeogenesis. Eur J Clin Nutr 1999, 53 Suppl 1(1):S107-111.
    8. Lupton JR, Brooks J, Butte N, Caballero B, Flatt J, Fried S: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academy Press: Washington, DC, USA 2002, 5:589-768.
    9. Landry MJ, Crimarco A, Gardner CD: Benefits of Low Carbohydrate Diets: a Settled Question or Still Controversial? Curr Obes Rep 2021, 10(3):409-422.
    10. Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jonsson T, Beardsley J, Johnson JA, Thabane L, Johnston BC: Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021, 372:m4743.
    11. Lennerz BS, Mey JT, Henn OH, Ludwig DS: Behavioral Characteristics and Self-Reported Health Status among 2029 Adults Consuming a "Carnivore Diet". Curr Dev Nutr 2021, 5(12):nzab133.
    12. Ben-Dor M, Sirtoli R, Barkai R: The evolution of the human trophic level during the Pleistocene. American journal of physical anthropology 2021, 175 Suppl 72:27-56.
    13. O’Hearn A: Can a carnivore diet provide all essential nutrients? Current Opinion in Endocrinology, Diabetes Obesity 2020, 27(5):312-316.
    14. Klement RJ: Was there a need for high carbohydrate content in Neanderthal diets? American Journal of Biological Anthropology 2022, 179(4):668-677.
    15. Westman EC: Is dietary carbohydrate essential for human nutrition? Am J Clin Nutr 2002, 75(5):951-953.
    16. O’Hearn A, Westman EC, Yancy WS, Wellington N: Nutritional aspects. In: Ketogenic. edn. Edited by Noakes TD, Murphy T, Wellington N, Kajee H, Rice SM: Academic Press; 2023: 71-104.
    17. Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN: Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 2020, 6(6):CD001903.
    18. Hagstrom H, Hagfors LN, Tellstrom A, Hedelin R, Lindmark K: Low carbohydrate high fat-diet in real life assessed by diet history interviews. Nutr J 2023, 22(1):14.
    19. Chourpiliadis C, Mohiuddin SS: Biochemistry, gluconeogenesis. In: StatPearls [Internet]. edn.: StatPearls Publishing; 2021.
    20. Taherizadeh M, Khoshnia M, Shams S, Hesari Z, Joshaghani H: Clinical Significance of Plasma Levels of Gluconeogenic Amino Acids in Esophageal Cancer Patients. Asian Pac J Cancer Prev 2020, 21(8):2463-2468.
    21. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI: Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 1991, 254(5031):573-576.
    22. Stewart WK, Fleming LW: Features of a successful therapeutic fast of 382 days' duration. Postgraduate medical journal 1973, 49(569):203-209.
    23. Thomson TJ, Runcie J, Miller V: Treatment of obesity by total fasting for up to 249 days. Lancet 1966, 2(7471):992-996.
    24. Cahill GF, Jr.: Fuel metabolism in starvation. Annual review of nutrition 2006, 26:1-22.
    25. Drenick EJ, Alvarez LC, Tamasi GC, Brickman ASJTJoci: Resistance to symptomatic insulin reactions after fasting. 1972, 51(10):2757-2762.
    26. Longo R, Peri C, Cricri D, Coppi L, Caruso D, Mitro N, De Fabiani E, Crestani M: Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry. Nutrients 2019, 11(10):2497.
    27. Zhang Y, Kuang Y, Xu K, Harris D, Lee Z, LaManna J, Puchowicz MA: Ketosis proportionately spares glucose utilization in brain. J Cereb Blood Flow Metab 2013, 33(8):1307-1311.
    28. Burke LM, Whitfield J, Heikura IA, Ross ML, Tee N, Forbes SF, Hall R, McKay AK, Wallett AM, Sharma AP: Adaptation to a low carbohydrate high fat diet is rapid but impairs endurance exercise metabolism and performance despite enhanced glycogen availability. The Journal of Physiology 2021, 599(3):771-790.
    29. Phinney SD, Bistrian BR, Wolfe RR, Blackburn GL: The human metabolic response to chronic ketosis without caloric restriction: physical and biochemical adaptation. Metabolism 1983, 32(8):757-768.
    30. Kackley ML, Brownlow ML, Buga A, Crabtree CD, Sapper TN, O'Connor A, Volek JS: The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults. Front Neurosci 2022, 16:971144.
    31. Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, Desai J, Waitzfelder B, Nichols GA, Lawrence JM et al: Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016, 39(3):363-370.
    32. Chantzaras A, Yfantopoulos J: Evaluating the Incidence and Risk Factors Associated With Mild and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes. Value Health Reg Issues 2022, 30:9-17.
    33. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y: Drug-induced hypoglycemic coma in 102 diabetic patients. Archives of internal medicine 1999, 159(3):281-284.
    34. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE: Diabetic ketoacidosis. Nat Rev Dis Primers 2020, 6(1):40.
    35. Cooper ID, Brookler KH, Kyriakidou Y, Elliott BT, Crofts CAJB: Metabolic phenotypes and step by step evolution of type 2 diabetes: A New paradigm. 2021, 9(7):800.
    36. Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, Hong D, Tian S, Sun C: Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Nutr Diabetes 2020, 10(1):38.
    37. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB: Chronic hypoglycemia increases brain glucose transport. Am J Physiol 1986, 251(4 Pt 1):E442-447.
    38. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN: Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 2002, 86(10):1615-1621.
    39. Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, Seyfried TN: Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer 2008, 7:37.
    40. Mulrooney TJ, Marsh J, Urits I, Seyfried TN, Mukherjee P: Influence of caloric restriction on constitutive expression of NF-kappaB in an experimental mouse astrocytoma. PLoS ONE 2011, 6(3):e18085.
    41. Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN: Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN Neuro 2010, 2(3):e00038.
    42. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN: The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 2007, 4:5.
    43. Wong W: Mitochondrial fission fueled by fasting. Sci Signal 2023, 16(797):eadk1008.

    The image in the post is from Resistance to Symptomatic Insulin Reactions after Fasting which is reference 35.

     

    Dr. Michael R. Eades received his BSCE degree in Civil Engineering from California Polytechnic University (Cal Poly), Pomona, California and his MD from the University of Arkansas Medical Sciences (UAMS).

    After completing training in General Surgery as UAMS, Dr. Eades (along with his wife) founded Medi-Stat Medical Clinics, a chain of general family medicine outpatient care centers in central Arkansas, where he practiced general family medicine for over a decade.

    In 1996, Dr. Eades co-authored (with Mary Dan Eades, MD), their first joint book project 'Protein Power', which became a national and international bestseller, selling over 3 million copies and spending 63 weeks on the NY Times Best Seller List.

    summerizerHistorical challenge

    • Plant-based messaging is cast as the old low-fat campaign in new clothes and as pressure away from low-carb eating.
    • Bread-centered stories about traditional Western diets are rejected; nineteenth-century meat markets, menus, and the Titanic menu are used as proof that meat was abundant before the twentieth century.
    • The central practical rule is evolutionary: the diet that shaped human physiology is the diet human beings do best on now.

    Clinical and trial bridge

    • Blake Donaldson’s all-meat practice is a modern clinical echo of a much older human pattern.
    • Mark Nathan Cohen’s warning is that medicine mistakes recent Western experience for the full range of human biology.
    • Modern randomized trials are added to the anthropological record, and the low-carb side is the clear winner over low-fat diets.

    Brains, guts, and energy

    • Leslie Aiello’s expensive-tissue hypothesis and Max Kleiber’s metabolic work anchor the main mechanism.
    • Humans have a metabolically expensive brain and a reduced gut, so the human body plan does not fit a bulky plant-based diet.
    • Meat solves the energy problem by shrinking gut demands and freeing metabolic budget for a larger brain.

    Plant bulk and scavenging

    • Great apes carry large abdomens because low-density plant foods require a lot of gut volume.
    • Early humans could move into a meat-heavy niche first by scavenging and later by hunting.
    • Briana Pobiner’s lion-kill work shows that large carcasses left enough calories behind to make scavenging a realistic bridge.

    Stable isotopes and trophic level

    • Carbon and nitrogen isotope ratios make long-term dietary reconstruction possible after soft tissue is gone.
    • Neanderthals sit at or above the carnivore range in isotope comparisons and are placed at a super-carnivore level.
    • Early modern humans also cluster at a very high trophic level, with animal food dominating protein intake.

    Foragers, farmers, and degeneration

    • The Kentucky comparison sets a meat-heavy hunter-gatherer population against a corn-bean-pumpkin farming population.
    • The farming group shows more iron-deficiency lesions, enamel defects, caries, abscesses, periosteal disease, infant mortality, and shorter life.
    • Agriculture turns intermittent stress into chronic degeneration, while the foraging group shows better baseline health.

    Cariogenic plants and agriculture

    • Severe dental destruction can come from heavy reliance on starchy or otherwise cariogenic plant foods even without refined sugar.
    • Jared Diamond’s verdict fits the skeletal record: agriculture is a biological catastrophe rather than a health advance.
    • A plant-focused side branch with massive chewing anatomy dead-ended, while the Homo line moved toward more meat and more brain.

    Egypt as a natural experiment

    • Ancient Egypt functions as a long-running wheat-based civilization trial centered on bread.
    • Bread, fruits, vegetables, honey, seed oils, fish, waterfowl, and only occasional red meat create a pattern equivalent to a modern low-fat prescription.
    • Egyptian statuary is read as evidence of abdominal obesity and male breast enlargement.

    Egyptian disease burden

    • Mummies and papyri put heart disease, catastrophic dental wear, obesity, and diabetes-like illness deep in antiquity.
    • Marc Armand Ruffer’s autopsies, the Ebers Papyrus, CT scans, and the Horus study place vascular disease throughout ancient Egypt.
    • Attempts to blame elite saturated-fat intake fail once isotope work shows similar diets across social classes and less than half of protein from animal sources.

    Final synthesis

    • Metabolic theory, scavenging ecology, stable isotopes, paleopathology, Egyptian mummies, and randomized trials all converge on the same answer.
    • Human beings are built for a lower-carbohydrate, meat-heavier diet than agricultural and modern plant-centered orthodoxies allow.
    • The practical prescription is blunt: cut the carbs.

    References

     

    TLDW - With medical supervision T2D can be reversible using a ketogenic nutritional therapy.

    Type 2 diabetes doesn’t just need to be managed; it can be reversed.

    For years, endocrinologist Dr. Mariela Glandt followed the conventional playbook: carefully adjusting medications, prescribing the latest drugs, and urging patients to eat whole grains and lean proteins. Yet her patients kept getting sicker, medications piled up, and their diabetes was treated as an inevitable, “progressive” disease.

    Then came a turning point.

    Through her research, Dr. Glandt came across scientific evidence that showed we could address insulin resistance head-on: by removing excess carbohydrates, patients could actually reverse their condition. No longer bound to insulin injections and endless prescriptions, they could reclaim their health.

    summerizerClinical shift

    • Years of diabetes care focused on glucose targets, medication adjustment, and newer drugs while patients remained under escalating medication burden.
    • Standard advice about the gym, whole grains, lean meats, fruits, and vegetables did not get patients off medications.
    • Type 2 diabetes can be reversed when insulin resistance is the root cause. Mechanism and diet
    • Type 2 diabetes is the body reaching a limit with sugar and carbohydrate load.
    • Carbohydrate removal removes the offending agent and diabetes fades.
    • Carbohydrates are not essential nutrients because the liver makes the glucose the body needs through gluconeogenesis.
    • A well-formulated low-carbohydrate diet is rich in natural proteins and fats.
    • Blood sugar goes down, normalizes, the body heals, and medications are peeled away. Patient impact
    • The first patient on the protocol lost 60 pounds in 6 months, dropped A1C from 10 to 5.4, and stopped every medication, including insulin.
    • The deeper change is fear lifting, hope returning, and health no longer feeling like a personal failure.
    • Seeing that change makes return to the earlier approach impossible.

    Scaling and evidence

    • Ketogenic diet use or therapeutic carbohydrate restriction reached about 4,000 patients before Ona Health was founded to scale the work, especially for Medicaid patients.
    • This approach reverses diabetes at a fractional cost of traditional therapies.
    • The country carries tens of millions of diabetes and prediabetes cases plus downstream costs from amputations, heart attacks, dialysis, depression, and the rest of the burden of type 2 diabetes.
    • Ketogenic diets are therapeutic, medicinal, and curative.
    • The evidence is strong enough that this approach would have received FDA approval long ago if it had been a drug.
    • ADA consensus language puts carbohydrate reduction at the top of the evidence base, and Tracey Brown reversed her own diabetes with a ketogenic diet.

    Policy and access

    • A humane and affordable option already exists that targets root cause, gives energy, lowers sugar cravings, and creates lasting satiety.
    • Federal and Medicaid pilots can spread this model across the country.
    • Food as medicine can expand access to healthy food and reverse chronic disease at scale.
    • The evidence is already in hand, the tools already exist, and the time is now.

    References

    This talk is just a sampler, and it should be noted virta health is doing the bulk of the t2d reversal publications.

    ADA Quote - "Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report" - http://doi.org/10.2337/dci19-0014

    Reducing overall carbohydrate intake for individuals with diabetes has demonstrated the most evidence for improving glycemia

     

    Dr. Donese Worden, NMD joins Professor Seyfried for an in-depth conversation covering the most important scientific findings and treatment tactics for managing cancer metabolically.

    summerizerCancer crisis and the new organization

    • Cancer deaths and projections remain severe enough that metabolic oncology needs organized bench-to-bedside research, education, and clinician support.
    • The new nonprofit joins researchers, oncologists, and physician scientists to move metabolic oncology forward with rigor and integrity.
    • Laboratory validation and patient care refine the same metabolic plan together. Finding a capable metabolic oncology clinician
    • A strong clinician knows the mitochondrial metabolic theory, stays current with Seyfried and related research, and can explain the field fluently.
    • Experience matters, but the key test is whether the clinician can individualize care for two patients with the same diagnosis.
    • A one-size-fits-all protocol is a warning sign.
    • Vague answers, defensiveness, overconfidence, and cure promises are reasons to leave.

    Core metabolic oncology plan

    • The press-pulse strategy is the working plan, and clinicians flesh it out in real patients while laboratory and clinical work keep improving it.
    • Ketogenic diet or at least low carbohydrate intake is foundational for most patients, alongside stress reduction, exercise, careful nutraceutical use, repurposed drugs, and often hyperbaric oxygen.
    • Nutritional ketosis is the platform, and the practical target is a glucose-ketone index around 2.0 or lower.
    • Multiple restricted dietary patterns can reach nutritional ketosis, including Mediterranean, carnivore, pescetarian, and vegan diets.
    • Time spent in the zone matters more than perfection, and flexibility matters because some patients feel tortured by chasing a perfect GKI.

    Stress, patient agency, and education

    • Stress management is a central part of cancer care because cancer-related stress raises corticosteroids and can make ketosis harder to reach.
    • Music, massage, acupuncture, meditation, breath work, exercise, and other stress-lowering practices belong on the clinical menu.
    • Patients do better when they take an active role in their care and come prepared to learn.
    • Random internet protocols and self-experiment stacks create confusion, liver strain, contraindications, and wasted effort.
    • Patients need a clinical guide who can choose the right tool, dose, and timing for the person in front of them.

    Supplements, vitamins, and personalization

    • Supplement quality is a major problem because many products are mislabeled, adulterated, or contaminated.
    • More is not better with supplements or vitamins, and excess vitamins can also feed tumor cells.
    • Supplement use needs a defined reason such as correcting a verified deficiency or exploiting a known vulnerability in cancer cells.
    • Metabolic oncology is highly personalized because bodies, lifestyles, sizes, deficiencies, and response patterns differ. Finding clinicians and building standards
    • The current clinician supply is small, so interim referral points include lists maintained by Seyfried and Dominic D'Agostino.
    • The long-term goal is certification of clinicians, clinics, and labs that can apply metabolic oncology knowledgeably and without compromising standard of care.
    • These practices also fit prevention and chronic disease risk reduction, not only advanced cancer care.
    • Supplement effects and other adjuncts still need broader logging and study across diverse patients.
    • People with cancer often arrive far from metabolic homeostasis, and bringing them back toward homeostasis improves the chances that repurposed drugs and procedures help.

    References

    view more: ‹ prev next ›